The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion
Clinical trial NCT02796950 · COMPLETED
Trial details
- NCT number
- NCT02796950
- Sponsor
- University of Aarhus
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-01-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.